ePT--the Electronic Newsletter of Pharmaceutical Technology, Apr 28, 2011 - Pharmaceutical Technology

Latest Issue
PharmTech

Latest Issue
PharmTech Europe

ePT--the Electronic Newsletter of Pharmaceutical Technology, Apr 28, 2011
News
FDA Releases Strategic Priorities for 2011-2015
By Christina I. Ortiz
FDA has released a list of its strategic priorities for the next five years to address new global challenges.
IMS: Growth in Drugs Stalls, Generic Use Up
By Amy Ritter
The IMS institute has released its report on the use of medicines in the United States during 2010.
Pfizer and Shanghai Pharmaceutical Partner in China
By Patricia Van Arnum
Shanghai Pharmaceutical and Pfizer have signed a memorandum of understanding for the companies to jointly pursue potential business opportunities in China.
Warner Chilcott to Axe 500 European Jobs
By Rich Whitworth
Warner Chilcott announced in a press release on Apr. 18, 2011, its intentions restructure, placing 500 Western European jobs on the line.
Week of Apr. 28, 2011: Company and People Notes: sanofi-aventis signs research pact with Stanford; Paul Maffuid joins AAIPharma Services; and More.
sanofi-aventis signs research pact with Stanford; Paul Maffuid joins AAIPharma Services; and More.

ADVERTISEMENT

LCGC E-mail Newsletters

Subscribe: Click to learn more about the newsletter
| Weekly
| Monthly
|Monthly
| Weekly

Survey
FDASIA was signed into law two years ago. Where has the most progress been made in implementation?
Reducing drug shortages
Breakthrough designations
Protecting the supply chain
Expedited reviews of drug submissions
More stakeholder involvement
Reducing drug shortages
70%
Breakthrough designations
4%
Protecting the supply chain
17%
Expedited reviews of drug submissions
2%
More stakeholder involvement
7%
View Results
Eric Langerr Outsourcing Outlook Eric LangerRelationship-building at Top of Mind for Clients
Cynthia Challener, PhD Ingredients Insider Cynthia ChallenerRisk Reduction Top Driver for Biopharmaceutical Raw Material Development
Jill Wechsler Regulatory Watch Jill Wechsler Changes and Challenges for Generic Drugs
Faiz Kermaini Industry Insider Faiz KermainiNo Signs of a Slowdown in Mergers
Click here